CoChat

A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Abstract

Purpose of review Migraine headaches are a neurologic disorder characterized by attacks of moderate to severe throbbing headache that are typically unilateral, exacerbated by physical activity, and associated with phonophobia, photophobia, nausea, and vomiting. In the USA, the overall age-adjusted prevalence of migraine in female and male adults is 22.3% and 10.8%, respectively.Recent findings Migraine is a disabling disease that ranks as the 8th most burdensome disease in the world and the 4th most in women. The overarching hypothesis of migraine pathophysiology describes migraine as a disorder of the pain modulating system, caused by disruptions of the normal neural networks of the head. The activation of these vascular networks results in meningeal vasodilation and inflammation, which is perceived as head pain. The primary goals of acute migraine therapy are to reduce attack duration and severity. Current evidence-based therapies for acute migraine attacks include acetaminophen, four nonsteroidal anti-inflammatory drugs (NSAIDs), seven triptans, NSAID-triptan combinations, dihydroergotamine, non-opioid combination analgesics, and several anti-emetics. Over-the-counter medications are an important component of migraine therapy and are considered a first-line therapy for most migraineurs. These medications, such as acetaminophen, ibuprofen, naproxen, and aspirin, have shown strong efficacy when used as first-line treatments for mild-to-moderate migraine attacks. The lower cost of over-the-counter medications compared with prescription medications also makes them a preferred therapy for some patients. In addition to their efficacy and lower cost, over-the-counter medications generally have fewer and less severe adverse effects, have more favorable routes of administration (oral vs. subcutaneous injection), and reduced abuse potential. The purpose of this review is to provide a comprehensive evidence-based update of over-the-counter pharmacologic options for chronic migraines.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11916-020-00852-0

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Research works printed but not linked: 2

  1. Mills RFN, Adams SS, Cliffe EE, Dickinson W, Nicholson JS. Xenobiotica the fate of foreign compounds in biological systems The Metabolism of Ibuprofen The Metabolism of Ibuprofen. 2008 [cited 2019 May 9]; Available from: https://www.tandfonline.com/action/journalInformation?journalCode=ixen20
  2. Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3–20. · DOI · Paper page

Cited by

See all 43

Metadata

Authors
Peck, J., Urits, I., Zeien, J., Hoebee, S., Mousa, M., Alattar, H., Kaye, A. D., & Viswanath, O.
Affiliations
  • Mount Sinai Medical Center (US)
  • Beth Israel Deaconess Medical Center (US)
  • University of Arizona College of Medicine- Phoenix (US)
  • Louisiana State University (US)
  • Creighton University (US)
Corresponding author
Peck, Jacquelin
Venue
Current Pain and Headache Reports
Published
2020-03-21
Volume
24
Issue
5
Pages
19-19
ISSN
  • 1531-3433 (ISSN-L)
  • 1534-3081
OpenAlex
W3012707125
Cited by
37
References
69
Citations by year
2026: 5 · 2025: 8 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 4
FWCI
0.83
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Current Pain and Headache Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
  • Health Sciences › Medicine › Clinical Neurology › Intracranial Aneurysms: Treatment and Complications
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
chronic migraine, over-the-counter drugs, acute migraine treatment, nonsteroidal anti-inflammatory drugs, paracetamol, triptans, dihydroergotamine, antiemetics, migraine pathophysiology, migraine prevalence, migraine burden
MeSH terms
Analgesics, Nonprescription Drugs, Humans, Migraine Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. https://app.cochat.ai/papers/10.1007/s11916-020-00852-0
The paper
Peck, J., Urits, I., Zeien, J., Hoebee, S., Mousa, M., Alattar, H., Kaye, A. D., & Viswanath, O. (2020). A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Current Pain and Headache Reports. https://doi.org/10.1007/s11916-020-00852-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.